Transdermal photodynamic therapy--a treatment option for rheumatic destruction of small joints?

Benjamin Funke1, Astrid Jungel, Stanislaw Schastak

  • 1Institute of Pathology, University Hospital Heidelberg, 69121 Heidelberg, Germany. benjamin.funke@med.uni-heidelberg.de

Abstract

Insights

Transdermal photodynamic therapy (tPDT) shows promise for rheumatoid arthritis treatment. This minimally invasive approach uses a novel photosensitizer to target joint tissue, offering a new synovectomy strategy.

Area of Science:

  • Photodynamic Therapy
  • Rheumatoid Arthritis Research
  • Medical Device Development

Background:

  • Rheumatoid arthritis (RA) management often involves synovectomy for small joint destruction.
  • Developing minimally invasive therapeutic strategies for RA is crucial.

Purpose of the Study:

  • To investigate the feasibility of transdermal photodynamic therapy (tPDT) for joint destruction.
  • To evaluate a novel near-infrared absorbing photosensitizer (PS) for tPDT.

Main Methods:

  • In vitro assessment of the photodynamic therapy (PDT) system functionality.
  • In vivo application of tPDT in a fibroblast-induced arthritis mouse model after PS administration.
  • Evaluation of therapeutic outcomes through joint swelling, serum amyloid A (SAA) levels, and histological analysis.

Main Results:

  • The PDT system demonstrated full functionality in vitro.
  • In vivo tPDT was well-tolerated by the animal subjects.
  • Photodynamic ablation of subcutaneous skeletal muscle tissue was achieved without observable skin damage.

Conclusions:

  • This study establishes the foundation for transdermal tissue accessibility via photodynamic processes.
  • tPDT presents a potential minimally invasive synovectomy strategy for rheumatoid arthritis.

Related Concept Videos

Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...